Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2024-09-09 Director's Dealing
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA - Mandatory notification of trade by primary insider
Director's Dealing Classification · 100% confidence The document details transactions involving 'Share options in Navamedic ASA' being exercised by individuals identified as 'Primary insider' (CEO, CBDO, Commercial Director). This structure, reporting transactions by directors/executives concerning their own holdings (or options thereof), directly corresponds to the definition of Director's Dealing (insider trades). The filing category 'DIRS' (Director's Dealing) is the most appropriate classification for reports detailing personal share transactions by company directors and executives.
2024-09-09 English
Navamedic ASA - Mandatory notification of trade by primary insider
Board/Management Information Classification · 99% confidence The document is titled 'Navamedic ASA - Mandatory notification of trade by primary insider' and details the exercise of share options by key executives (CEO, CBDO, Commercial Director) and the subsequent subscription for new shares. This directly relates to personal share transactions by company directors and executives, which falls under the definition of Director's Dealing. The filing code for this activity is DIRS. The document is short and reports specific insider transactions, confirming the classification.
2024-09-09 English
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
Share Issue/Capital Change Classification · 98% confidence The document explicitly states its purpose: 'RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS'. It details the issuance of new shares (230,000) to settle exercised share options, resulting in a change to the company's share capital. This directly corresponds to the definition of 'Share Issue/Capital Change' (SHA), which covers announcements regarding new share issues or capital structure changes.
2024-09-09 English
Navamedic ASA - Mandatory notice of trade
Director's Dealing Classification · 100% confidence The document text consists of a structured table detailing a transaction involving shares of Navamedic ASA. Key fields include 'Description of the financial instrument' (Shares in Navamedic ASA), 'Nature of the transaction' (Sold shares), and details about the price, volume, date (21.08.2024), and location (Oslo Stock Exchange). This format and content strongly indicate a mandatory disclosure of personal share transactions by a director or closely associated party of an insider. This aligns directly with the definition for Director's Dealing (DIRS).
2024-08-21 English
Navamedic ASA - Mandatory notice of trade
Director's Dealing Classification · 99% confidence The document is titled 'Mandatory notice of trade' and explicitly states that a primary insider's closely related party (Agnvicen AB) sold shares of Navamedic ASA. It details the number of shares sold and the price, and mentions disclosure requirements under MAR Article 19. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors or closely related parties). The code for Director's Dealing is DIRS.
2024-08-21 English
Navamedic ASA - Mandatory notice of trade
Director's Dealing Classification · 100% confidence The document text clearly details a transaction involving shares by a 'person discharging managerial responsibilities' (Rune Wahl, a Board member and Primary Insider) in Navamedic ASA. It specifies the nature of the transaction ('Acquired shares'), the price, volume, date (20.08.2024), and the location (Oslo Stock Exchange). This structure is characteristic of mandatory insider trading disclosures, which fall under the category of Director's Dealing (DIRS) in this classification scheme.
2024-08-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.